Headache News and Research

Latest Headache News and Research

Hypertension linked to heavy drinking

According to British researchers the relationship between heavy drinking and high blood pressure is more significant than previously thought.

4 Mar 2008

FDA grants priority review for ACIPHEX (rabeprazole sodium) sNDA for treatment of GERD in adolescents

Eisai Corporation of North America, a wholly-owned subsidiary of Tokyo-based Eisai Co., Ltd., has announced that the Food and Drug Administration (FDA) has accepted an ACIPHEX supplemental New Drug Application (sNDA) for the short-term (up to eight weeks) treatment of gastroesophageal reflux disease (GERD) in patients ages 12-16.

3 Mar 2008

FDA approves Nexium for gastroesophageal reflux disease in children

The U.S. Food and Drug Administration approved Nexium (esomeprazole magnesium) for short-term use in children ages 1-11 years for the treatment of gastroesophageal reflux disease (GERD).

28 Feb 2008

Plane diverted for woman with meningococcal disease

According to Australian Health authorities a woman who became ill on a flight from Auckland to Perth last night is suspected to have had meningococcal disease.

26 Feb 2008

Abbott receives approval for HUMIRA (Adalimumab) for polyarticular juvenile idiopathic arthritis

Abbott has announced that it has received U.S. Food and Drug Administration (FDA) approval to market HUMIRA (adalimumab) as a treatment to reduce signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis (JIA) in patients four years of age and older.

26 Feb 2008

Mosquito bourne diseases cause concern in three areas of Australia

Australian Health officials have issued public health warnings about mosquito bourne diseases in three areas.

25 Feb 2008

XYNTHA approved for teatment of hemophilia A by FDA

Wyeth Pharmaceuticals, a division of Wyeth ( NYSE:WYE) , announced today that it has received approval from the U.S. Food and Drug Administration for XYNTHA(TM) (Antihemophilic Factor [Recombinant], Plasma/Albumin-Free), a recombinant factor VIII product, for patients with hemophilia A for both the control and prevention of bleeding episodes and surgical prophylaxis.

22 Feb 2008

Calls to doctor's office may delay stroke treatment

Calling a primary care doctor instead of 9-1-1 at the first sign of a stroke can delay patients from reaching an emergency room during the most critical period - the first three hours after onset of stroke symptoms, researchers reported at the American Stroke Association's International Stroke Conference 2008.

21 Feb 2008

Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder

Common antidepressant drugs such as Prozac and Zoloft can be effective treatment options for obsessive compulsive disorder (OCD), according to a new review of studies.

20 Feb 2008

Winter in China brings another bird flu death

The man, Mr Li was from Jianghua County, Yongzhou City in central Hunan Province, he developed a fever and headache and was hospitalised on January 22nd, but despite treatment his symptoms worsened and he died at 5 p.m. on January 24th after all rescue attempts had failed.

18 Feb 2008

Amantadine and rimantadine for influenza A in children and the elderly

The antiviral drug amantadine can prevent some cases of influenza in children, and the related medication rimantadine can reduce fever in youngsters who have the flu, according to a new review of evidence.

8 Feb 2008

Enbrel shown to significantly reduced levels of C-reactive protein

Amgen and Wyeth Pharmaceuticals, a division of Wyeth have announced findings from a retrospective analysis, which demonstrated that ENBREL reduced C-reactive protein (CRP), a marker of inflammation, in patients with moderate to severe plaque psoriasis following 12 weeks of treatment. Median reduction in CRP levels was 10 times greater in the ENBREL treated group compared to the placebo treated group.

5 Feb 2008

FDA approves only once-daily inhaled corticosteroid for children

Schering-Plough Corporation has announced that the U.S. Food and Drug Administration (FDA) has approved ASMANEX TWISTHALER 110 mcg (mometasone furoate inhalation powder) for the maintenance treatment of asthma as a preventive therapy in patients 4 to 11 years of age.

4 Feb 2008

Scientists render Ebola harmless in the laboratory

Scientists in the United States say that they have found a way to make the lethal Ebola virus harmless in the laboratory.

23 Jan 2008

Listeria at a milk processing plant to blame for 3 deaths

Public health officials in the U.S. investigating an outbreak of listeria have found 16 samples of listeria bacteria at a milk processing plant.

20 Jan 2008

Arthritis drug Etanercept clears up symptoms of psoriasis

New research from the United States has found that a drug commonly used to treat arthritis significantly reduces the symptoms of psoriasis in children.

20 Jan 2008

FDA approves Tysabri to treat Crohn's disease

The U.S. Food and Drug Administration has approved Tysabri (natalizumab) for the treatment of moderate-to-severe Crohn's disease in patients with evidence of inflammation who have had an inadequate response to, or are unable to tolerate, conventional Crohn's disease therapies.

14 Jan 2008

Seasonal flu levels trigger use of antiviral drugs

The Health Protection Agency has confirmed that the rate at which influenza viruses are now circulating in England has reached the point which triggers the use of antiviral drugs.

11 Jan 2008

Contaminated milk responsible for three deaths and a miscarriage

The latest incident in the United States involving bacteria-contaminated milk has claimed the lives of three elderly men and caused at least one pregnant woman to miscarry since last June.

9 Jan 2008

Dengue seen as potential threat to US public health

A disease most Americans have never heard of could soon become more prevalent if dengue, a flu-like illness that can turn deadly, continues to expand into temperate climates and increase in severity, according to a new commentary by Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and David M. Morens, M.D., Fauci's senior scientific advisor.

9 Jan 2008